FATE
FATE
NASDAQ · Biotechnology

Fate Therapeutics Inc

$2.38
+0.00 (+0.00%)
As of Sep 29, 10:14 PM ET ·
Analyst Consensus
Buy
18
Analysts
High
Coverage
Buy 11 61%
Hold 7 39%
Sell 0 0%
Price Target
Analyst Price Target +141.6% upside
Low Target $4.43
Average Target $5.75
High Target $6.69
Current Price $2.38
Current
$2.38
Target
$5.75
$4.43 $5.75 avg $6.69
Scenario Analysis
Bear Case
$4.43
86.1%
Low target
Base Case
$5.75
+141.6%
Avg target
Bull Case
$6.69
+181.1%
High target
Risk/Reward
2.1x
Favorable
Price in Context
52-Week High
$3.23
-26.3% from high
52-Week Low
$0.95
+150.5% from low
Target vs 52W High
$5.75
+78.0% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 39 82% $257.58 -2.2%
AMGN
Amgen Inc
Hold 43 47% $190.87 -54.9%
GILD
Gilead Sciences Inc
Strong Buy 37 81% $362.68 +139.7%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 36 81% $438.34 -16.8%
REGN
Regeneron Pharmaceuticals
Buy 38 68% $76.80 -89.8%
MRNA
Moderna Inc
Hold 30 37% $149.45 -26.5%
NTRA
Natera Inc
Strong Buy 30 87% $142.91 -65.5%
RVMD
Revolution Medicines Inc
Strong Buy 28 93% $114.11 -44.2%